US DHHS Orders for Bulk Supply of 2009 H1N1 Influenza Vaccine Antigens and Squalene-containing Adjuvants
| Manufacturer | Bulk Vaccine Antigen | Oil-In-Water Bulk Adjuvant |
| Novartis | $150 million | $139 million |
| GlaxoSmithKline | $ 38 million | $144 million |
| Sanofi Pasteur | $191 million |
|
| CSL Biotherapies | $180 million |
|
| MedImmune | $ 90 million |
|
| Total | $649 million | $283 million |
No comments:
Post a Comment